Qingdao Haier Biomedical Co (SHSE:688139) Risk Assessment

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Qingdao Haier Biomedical Co is: High Risk: Good fundamentals, beware of shrinking business.

Competitive Comparison of Qingdao Haier Biomedical Co's Risk Assessment

For the Medical Devices subindustry, Qingdao Haier Biomedical Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qingdao Haier Biomedical Co's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qingdao Haier Biomedical Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Qingdao Haier Biomedical Co's Risk Assessment falls into.

Qingdao Haier Biomedical Co (SHSE:688139) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Qingdao Haier Biomedical Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Haier Road, Branding Building, Qingdao, CHN, 266101

Website

http://www.haiermedical.com

Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.

Executives

Zhang Jiang Tao	Core technical personnel
Liu Ji Yuan	Core technical personnel
Teng Pei Kun	Core technical personnel
Wang Guang Sheng	senior management
Gong Yi	Director
Huang Yan Li	senior management
Chen Hai Tao	Senior management, core technical personnel
Liu Zhan Jie	Directors, senior managers, core technical personn
Mo Rui Juan	senior management
Wang Wen Fu	Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines